ATAIAtai Beckley Inc.Healthcare · Biotechnologyas of 2026-09-16
Horizon

Issued 2026-09-16 at $7.35 · now $7.35 (2026-09-10, +0.0% since)

Based on its own history, a month from the 2026-09-16 close, ATAI has typically landed between $5.08 and $10.70 — a range of −30.9% to +45.6% from the issuance price $7.35.

Range of outcomes in historically similar periods — not a price prediction. Ranges are scored publicly on /methodology.
  • Actual close
  • Typical path (median)
  • Middle 50% of outcomes
  • 90% range

1,291 overlapping 1 month windows · 2021-06-212026-08-11 · basis climatology · forecast (batch). Probability up 53.9% (90% CI 51.756.1%, ≈1,408 obs).

The cone is anchored at the 2026-09-16 issuance close ($7.35) — the price the forecast resolves against on 2026-10-15, not the latest close. The drawn path shape is illustrative (bands widen with √t); every labeled number is real — the anchor, the scored batch p90/IQR endpoints, and the typical move.

Where ATAI has typically landed a month from the 2026-09-16 close of $7.35 — the range is history, not a prediction.

$5.08worst · -30.9%$10.7best · +45.6%
  • now $7.35 (+0.0%)
  • typicalThe typical outcome — half of similar past periods did better and half did worse (not an average, so a few wild periods don't skew it). $7.18 (-2.4%)
  • middle 50%The central range of outcomes — half of similar past periods landed inside it, a quarter finished above, a quarter below. $6.12$8.23
  • 90% rangeA nine-in-ten range — in about nine of every ten similar past periods the outcome stayed within these bounds. $5.08$10.7
Actual 1-month windows behind the coneiEvery overlapping 1-month window in this security's own price history was ranked by realized return; shown are the 3 worst and 3 best of 1,291 windows spanning 2021-06-21 to 2026-09-10. Not cherry-picked — these are the extremes of the full sample. Max drop / max rise are the deepest and highest points reached within each window. See /methodology.
StartReturnMax dropMax rise
3 worst
2022-12-07−48.1%−48.1%+3.5%
2021-11-15−46.9%−46.9%+0.0%
2022-12-08−46.8%−49.8%+0.0%
3 best
2025-06-23+92.1%+0.0%+92.1%
2023-12-07+87.2%−4.3%+87.2%
2026-06-15+86.2%+0.0%+86.2%

1,291 overlapping windows · 2021-06-212026-09-10 · not cherry-picked

Seasonality · by month iHow this security has tended to do in each calendar month historically — a frequency, never a prediction.

iFor each calendar month, the share of years this security closed higher than the month before, and the average month-over-month return, over ~6 years of its own price history. Cells are shaded by average return. This is historical frequency, not a prediction — no month is a signal.
Jan
40%
−5.7%
n=5
Feb
60%
+3.7%
n=5
Mar
40%
−5.1%
n=5
Apr
80%
+3.6%
n=5
May
40%
+5.7%
n=5
Jun
20%
−3.3%
n=5
Jul
83%
+25.2%
n=6
Aug
67%
−1.1%
n=6
Sep
33%
−7.8%
n=6
Oct
20%
−3.0%
n=5
Nov
40%
+2.8%
n=5
Dec
40%
−7.9%
n=5

Up-frequency and average month-over-month return · historical frequency, not a prediction

Reported insider & political trades

Every Form 4 the people closest to this company have filed with the SEC — plotted against the share price, aggregated by month, and shown with the gap between when each trade happened and when it was disclosed. A public record, not advice.

Share price & reported tradesMonthly open-market valueReporting lag — trade date to filing date2026-092026-082026-072026-062026-052026-042026-032026-022026-012025-122025-112025-102025-092025-08$7$32025-08: 1 open-market purchase, $19.0M2026-01: 1 open-market sale, $154K2026-03: 1 open-market sale, $355K2026-04: 1 open-market sale, $213K2026-06: 2 open-market sales, $442K2026-07: 1 open-market sale, $496K↑ buys↓ sales
DatePersonRoleActionShares @ priceValueOwnership Δvs S&P 1mvs S&P 6mOwned afterFiling

The vs-S&P columns are a labeled look-back on what the stock did after each filing, measured against the index over the same window. Descriptive history, not a claim about the person or a reason to trade.

300 award / exercise / gift records — not counted as purchases

Awards, option exercises, gifts and tax-withholding disposals are shown separately and never counted as open-market purchases or sales — they carry no conviction information.

DatePersonRoleActionSharesOwned afterFiling
2026-09-11Angermayer ChristiandirectorDisposition624,0000Form 4
2026-09-11Angermayer ChristiandirectorDisposition64,0000Form 4
2026-09-11Angermayer ChristiandirectorDisposition131,6980Form 4
2026-09-11Angermayer ChristiandirectorDisposition1,247,9320Form 4
2026-09-11Angermayer ChristiandirectorDisposition121,9680Form 4
2026-09-11JOHNSON SABRINA MARTUCCIdirectorDisposition64,0000Form 4
2026-09-11JOHNSON SABRINA MARTUCCIdirectorDisposition103,0000Form 4
2026-09-11JOHNSON SABRINA MARTUCCIdirectorDisposition121,9680Form 4
2026-09-11Braunstein ScottdirectorDisposition206,0000Form 4
2026-09-11Angermayer ChristiandirectorDisposition17,9300Form 4
2026-09-11Angermayer ChristiandirectorDisposition1,247,9320Form 4
2026-09-11Angermayer ChristiandirectorDisposition559,2320Form 4
2026-09-11Angermayer ChristiandirectorDisposition53,398,2140Form 4
2026-09-11Angermayer ChristiandirectorDisposition1,799,3020Form 4
2026-09-11Angermayer ChristiandirectorDisposition64,0000Form 4
2026-09-11Angermayer ChristiandirectorDisposition17,9300Form 4
2026-09-11Angermayer ChristiandirectorDisposition1,247,9320Form 4
2026-09-11Angermayer ChristiandirectorDisposition131,6980Form 4
2026-09-11Angermayer ChristiandirectorDisposition103,0000Form 4
2026-09-11Angermayer ChristiandirectorDisposition121,9680Form 4
2026-09-11JOHNSON SABRINA MARTUCCIdirectorDisposition64,0000Form 4
2026-09-11JOHNSON SABRINA MARTUCCIdirectorDisposition103,0000Form 4
2026-09-11HERSHBERG ROBERTdirectorDisposition48,8580Form 4
2026-09-11HERSHBERG ROBERTdirectorDisposition404,8690Form 4
2026-09-11HERSHBERG ROBERTdirectorDisposition62,3940Form 4
2026-09-11HERSHBERG ROBERTdirectorDisposition103,0000Form 4
2026-09-11HERSHBERG ROBERTdirectorDisposition121,9680Form 4
2026-09-11Braunstein ScottdirectorDisposition208,0630Form 4
2026-09-11Angermayer ChristiandirectorDisposition559,2320Form 4
2026-09-11Angermayer ChristiandirectorDisposition53,398,2140Form 4
2026-09-11Angermayer ChristiandirectorDisposition1,799,3020Form 4
2026-09-11Angermayer ChristiandirectorDisposition624,0000Form 4
2026-09-11Angermayer ChristiandirectorDisposition64,0000Form 4
2026-09-11Angermayer ChristiandirectorDisposition17,9300Form 4
2026-09-11Angermayer ChristiandirectorDisposition131,6980Form 4
2026-09-11Angermayer ChristiandirectorDisposition103,0000Form 4
2026-09-11Braunstein ScottdirectorDisposition103,0000Form 4
2026-09-11Braunstein ScottdirectorDisposition56,8180Form 4
2026-09-11Braunstein ScottdirectorDisposition206,0000Form 4
2026-09-11Braunstein ScottdirectorDisposition103,0000Form 4

Source: SEC Form 4 filings. Each row links to its original filing.

Across 2012–2021, stocks where a CEO, C-suite officer, or director had recently made an open-market common-stock purchase ran about +28 bp per month above the universe average (n=34,268 stock-weeks). A historical tendency, not a prediction.

Congressional disclosures

No congressional trades disclosed for this company.

Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.